Real-time enrollment status for this liver diseases, alcoholic clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 6:15 PM UTC
| NCT Number | NCT07791043 |
| Recruiting Status | Recruiting |
| Condition | Liver Diseases, Alcoholic |
| Phase | PHASE2 |
| Target Enrollment | 274 participants |
| Active Locations | 3 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | September 30, 2026 (1 week ago) |
As of October 12, 2026: Clinical trial NCT07791043 is currently recruiting participants. This phase2 study for liver diseases, alcoholic is actively seeking new participants at 3 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07791043 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07791043 was last updated 1 week ago (September 30, 2026). HelloStudys verifies this status automatically.